Organization · Event Organizer

Next Generation Undruggable 2023

Next Generation Undruggable 2023 is an organization based in Boston that focuses on advancing drug discovery efforts for hard-to-drug targets. It serves as a platform for industry professionals to discuss scientific and commercial challenges in the biotechnology and pharmaceutical sectors.

Event OrganizerEvent host

Overview

What Next Generation Undruggable 2023 does

What Next Generation Undruggable 2023 is

Next Generation Undruggable 2023 is an organization based in Boston that focuses on advancing drug discovery efforts for hard-to-drug targets. It serves as a platform for industry professionals to discuss scientific and commercial challenges in the biotechnology and pharmaceutical sectors.

How it participates in the startup ecosystem

The current public profile supports event host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status
Active
Organization type
Event Organizer
Founded
Founded in 2023
Approximate age
About 3 years
Structured capabilities
Event host
Last reviewed
April 5, 2026

Official channels

Find Next Generation Undruggable 2023 elsewhere

Open the official website or a supported primary organization account.

Capability profile

Next Generation Undruggable 2023 as an event host

Event focus

Next Generation Undruggable invests in and promotes discussions around novel modalities and innovative approaches to drug discovery. The organization emphasizes the importance of cross-company partnerships and the exploration of new methods to tackle difficult-to-drug targets across various therapeutic areas.

Format narrative

Next Generation Undruggable hosts an annual conference as part of the Future of R&D Week, featuring discussions on the latest developments in drug discovery and the application of AI in pharmaceutical research and clinical development.

Participant value

The conference provides a platform for discussions among industry professionals, academics, and investors regarding the scientific and commercial challenges in drug development.

Format and cadence

Event types
conference
Recurrence
annual
Modality
in-person
Startups can present
No

Availability

Registration state
Not currently accepting
Next event location
Boston, MA

Audience and fit

Audience
Founders · Investors · Researchers

Speakers and past editions

Speakers

Notable speakers include Gregory Verdine, PhD (Co-Founder, President and CEO, LifeMine Therapeutics), Stephen Fawell, PhD (Vice President, Head Oncology Discovery, AstraZeneca), and Becky Pferdehirt (Partner, Andreessen Horowitz).

Past editions

The 2023 event took place on October 3rd in Boston, MA, and included discussions on the latest developments in drug discovery and the application of AI in pharmaceutical research and clinical development.

Connected ecosystem

Continue from Next Generation Undruggable 2023

These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.

Common questions

What to know about Next Generation Undruggable 2023

Upseed classifies Next Generation Undruggable 2023 under the Event Organizer organization type. Its current public profile includes event host capabilities.

Next step

Keep comparing startup organizations

Return to the organization index or continue through a verified sector, place, peer, or program connected to this profile.

Source and update disclosure

Know what this page is based on

Source basis

Public organization and program material, official websites, and structured Upseed records.

Last reviewed

April 5, 2026

Known limits

Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.

Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.